News >

Eisai And Merck to Collaborate on Lenvatinib Mesylate

Jason Harris
Published: Thursday, Mar 08, 2018

Roger M. Perlmutter, MD, PhD

Roger M. Perlmutter, MD, PhD
Lenvatinib mesylate (Lenvima) will be developed and commercialized in a collaboration between its creator, Japan’s Eisai Co. Ltd, and the pharmaceutical giant Merck.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Advancing the Treatment of Bladder Cancers Using Evidence-Based Immuno-Oncology StrategiesJul 30, 20191.0
Medical Crossfire®: Where Are We Headed in the Treatment of Triple-Negative Breast Cancer?Jul 31, 20191.5
Publication Bottom Border
Border Publication